单位：人民币万元 注：合计数与加计数存在差异，系数字进行四舍五入计算形成的尾差（下同）。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688322 证券简称：奥比中光 公告编号：2025-065 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》（以下简称"《监管规则》"）、《上海证券交易所科创板股票上市 规则》《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》（以下简称"《自律监管指 引第1号》"）及《奥比中光科技集团股份有限公司募集资金管理制度》（以下简称"《管理制度》"）等 有关规定，奥比中光科技集团股份有限公司（以下简称"公司"）编制了《2025年半年度募集资金存放与 实际使用情况的专项报告》，具体内容如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意奥比中光科技集团股份有限公司首次公开发行股票注册的批 复》（证监许可〔2022〕849号），公司由联席主承销商中信建投证券股份有限公司（以下简称"中信建 投 ...

Group 1 - Wanhua Chemical reported a 25.10% decrease in net profit for the first half of 2025, with revenue of 90.90 billion yuan, down 6.35% year-on-year [1][2] - The company's net profit attributable to shareholders was 6.12 billion yuan, while the net profit excluding non-recurring items was 6.24 billion yuan, both showing significant declines [1][2] - Despite challenges such as weak international demand and geopolitical tensions, the chemical industry in China maintained stable development due to domestic consumption upgrades and diversified export markets [2] Group 2 - Satellite Chemical achieved a 33.44% increase in net profit for the first half of 2025, with total assets reaching 69.30 billion yuan, up 5.58% year-on-year [4][5] - The company reported revenue of 23.46 billion yuan, a 20.93% increase compared to the previous year, demonstrating resilience in a complex environment [4][5] - The company is focusing on technological innovation and plans to invest 3 billion yuan in high-performance catalyst projects [5] Group 3 - Shengnong Development reported a 22.02% increase in sales revenue for July 2025, reaching 2.13 billion yuan, with significant growth in both poultry and processed meat segments [6][7] - The company noted a strong performance in high-value channels, with retail channel revenue growing over 30% year-on-year [7] Group 4 - Desay SV reported a 45.82% increase in net profit for the first half of 2025, with revenue of 14.64 billion yuan, up 25.25% year-on-year [8] - The smart cockpit and smart driving businesses contributed significantly to the revenue growth, with sales of 9.46 billion yuan and 4.15 billion yuan respectively [8] Group 5 - New Qianglian reported a remarkable 496.60% increase in net profit for the first half of 2025, with revenue of 2.21 billion yuan, up 108.98% year-on-year [16] - The company demonstrated strong growth in its financial performance, indicating effective operational strategies [16] Group 6 - Fuda Co. reported a 98.77% increase in net profit for the first half of 2025, with revenue of 937 million yuan, up 30.26% year-on-year [18] - The company showed significant growth in net profit excluding non-recurring items, indicating strong operational performance [18] Group 7 - Tianzhun Technology reported a revenue increase of 10.32% for the first half of 2025, reaching 597 million yuan, but still recorded a net loss of 14 million yuan [19] - The company’s total assets grew by 9.99% year-to-date, indicating a positive trend in asset management [19] Group 8 - Huafeng Chemical reported a 35.23% decrease in net profit for the first half of 2025, with revenue of 12.14 billion yuan, down 11.7% year-on-year due to industry downturns [28] - The company faced challenges with declining product prices across various segments, impacting overall profitability [28] Group 9 - The company Zhishang Technology plans to acquire 99.86% of Hengyang Data for 1.15 billion yuan, focusing on AI and cloud computing solutions [29] - This acquisition aims to enhance the company's capabilities in intelligent computing and data processing [29] Group 10 - Huangshanghuang plans to acquire 51% of Lixing Food for 495 million yuan, which will allow it to gain control over the food manufacturing company [30] - This acquisition is part of the company's strategy to expand its product offerings and market presence [30] Group 11 - Beida Pharmaceutical faces significant revenue and profit declines due to the termination of its business cooperation with Peking University International Hospital, projecting a loss of approximately 600 million yuan in sales [31] - The company is exploring new directions for transformation, but faces uncertainty regarding its future operations [31]

证券日报网讯 8月11日晚间，奥比中光发布公告称，公司第二届董事会第十七次会议审议通过了《2025 年半年度报告全文及其摘要》等多项议案。 （文章来源：证券日报） ...

人民财讯8月11日电，【热点】 【经营业绩】 露笑科技：筹划发行H股并在香港联交所上市。 中国重工：自8月13日起连续停牌直至终止上市。 海康威视：董事长提议实施2025年中期分红，拟10派4元（含税）。 北大医药：全资子公司北医医药6月以来主营业务已基本中止。 皇庭国际：深圳皇庭广场将被司法拍卖，起拍价30.53亿元。 *ST苏吴：控股孙公司就Regen Biotech违约提起仲裁并获受理立案。 ST易购：拟支付2.2亿元与家乐福方达成债务和解协议。 上海建科：公司董事陈为接受纪律审查和监察调查。 金鹰重工：与新藏铁路有限公司还未开展相关业务。 三连板吉视传媒：公司未参与投资目前上映的影片。 二连板天顺股份：公司未参与新藏铁路工程项目。 东芯股份：上海砺算未纳入公司合并报表范围。 【并购】 新晨科技：终止收购天一恩华96.96%股权事项。 光库科技：拟购买苏州安捷讯光电100%股权，12日复牌。 *ST生物：筹划购买慧泽医药51%股权，预计构成重大资产重组。 东方国信：拟控股视拓云，深化智能算力领域布局。 九鼎投资：拟控股南京神源生，切入机器人产业链关键环节。 煌上煌：拟4.95亿元收购立兴食品51%股权。 ...

Core Insights - The rapid development of AI large models has led to significant progress for the company, marking a "turning point" in its operations [1] - In the first half of 2025, the company reported revenue of 435 million yuan, a year-on-year increase of 104.14%, and a net profit of 60.19 million yuan, up 212.77% [1] Group 1: Business Development - The company has signed a cooperation agreement with Horizon Robotics and its subsidiary, Diguo Robotics, to deepen collaboration in the field of robot intelligence [2] - The company has developed a comprehensive range of 3D visual perception products for various types of robots, including service robots, industrial robots, and humanoid robots [2] - The company is building a "robot and AI visual industry platform" to enhance research and development in 3D visual perception technology [2] Group 2: Service Robots - The company has established partnerships with several domestic and international service robot clients, covering applications such as lawn mowing, hotel delivery, and commercial cleaning [3] - In collaboration with RoboCare, a leading Korean nursing robot company, the company has launched multiple robot products aimed at elderly care [3] - The company's 3D visual sensors have been successfully integrated into humanoid robots, with notable achievements such as winning the world's first humanoid robot marathon [3] Group 3: Industry Applications - The company is accelerating the promotion and implementation of 3D visual perception technology across various industries, driven by advancements in large model technology and intelligent device upgrades [4] - The company has strengthened market promotion efforts, leading to increased applications of 3D visual sensors in offline retail, self-service kiosks, and other payment scenarios [4] - As a core supplier for Alipay's "tap to pay" service, the company has facilitated the large-scale implementation of this innovative payment method in elevator scenarios [4][5] Group 4: Innovation and Patents - The company is in a critical development phase for 3D visual perception, with numerous potential applications and market opportunities [6] - At the 2025 World Robot Conference, the company launched new perception products for the robotics sector, including the PulsarME450 and Gemini345Lg [6] - The company has applied for a total of 1,903 patents, including 990 invention patents, and has obtained 1,112 patents, with a focus on enhancing its core technologies [7]

（编辑 何成浩） 证券日报网讯 8月11日晚间，奥比中光发布公告称，公司2025年上半年实现营业收入为435，469， 288.84元，同比增长104.14%；归属于上市公司股东的净利润为60，190，103.28元，归属于上市公司股 东的扣除非经常性损益的净利润为30，189，151.39元。 ...

业绩增长主要系报告期营业收入大幅增加所致。 智通财经APP讯，奥比中光(688322.SH)披露2025年半年度报告，报告期公司实现营收4.35亿元，同比增 长104.14%;归属于上市公司股东的净利润6019万元，同比扭亏为盈;扣非净利润3019万元，同比扭亏为 盈;基本每股收益0.15元。 ...

业绩增长主要系报告期营业收入大幅增加所致。 智通财经APP讯，奥比中光(688322.SH)披露2025年半年度报告，报告期公司实现营收4.35亿元，同比增 长104.14%;归属于上市公司股东的净利润6019万元，同比扭亏为盈;扣非净利润3019万元，同比扭亏为 盈;基本每股收益0.15元。 ...

Group 1 - The company achieved operating revenue of 435.47 million yuan in the first half of 2025, representing a year-on-year growth of 104.14% [1] - The net profit attributable to shareholders reached 60.19 million yuan, an increase of 113.56 million yuan compared to the same period last year [1] - The overall business scale and profitability of the company are continuously improving, indicating a clear upward trend [1] Group 2 - The company's strategy of "technology innovation investment - commercial results transformation" has accelerated, focusing on breakthroughs in the essential downstream market [2] - Continuous optimization of product performance and the introduction of differentiated, high-cost performance new products have led to sustained improvement in overall operational conditions [2] - The company possesses comprehensive R&D capabilities and a full-spectrum technology layout, providing a strong foundation for technological iteration and innovation [2] Group 3 - The rapid development of large AI models has yielded results from the company's long-term cultivation and layout in various innovative downstream application fields [2] - The company has successfully reached an "operational inflection point" and will continue to explore emerging fields and products within the industry [2] - The mission is to enable all terminals to understand the world, aiming to build a "robot and AI vision industry platform" and become a global leader in the 3D sensing industry [2]

格隆汇8月11日丨奥比中光(688322.SH)公布，2025年上半年，公司实现营业收入43,546.93万元，同比增 长104.14%；归属于上市公司股东的净利润6,019.01万元，较上年同期增加11,356.32万元。公司整体业 务规模和盈利能力不断提升，向好趋势明确。 2025 年上半年，公司的"技术创新投入－商业成果转化"战略加速落地催化，并聚焦刚需下游市场进行 业务突破，不断优化产品性能，推出差异化、高性价比的新产品，整体经营情况持续向好。同时，公司 全栈式的研发能力和全领域的技术路线布局，为技术迭代创新提供了源源不断的底层动力，如今在包括 具身智能机器人、各类 AI 端侧硬件升级等赛道，公司均具备明显的先发、技术及产品规模化等优势。 随着人工智能大模型的快速发展，公司多年来在各类创新下游应用领域的培育和布局初见成效，公司成 功迎来"经营拐点"。未来，公司将持续关注行业内的新兴领域与产品，并积极探索其与公司技术相结合 的应用场景，围绕以自研核心技术和产品为刚需的下游在全球范围开拓潜在客户，持续提升公司的业务 表现和经营业绩，以"让所有终端都能看懂世界"为使命，致力于在人工智能时代打造"机器人与AI ...